VIVO Cannabis Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Joseph Louis Raymond Laflamme
- Full Time Employees
- 155
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 126 Vanluven Road Napanee ON Canada K7R 3L2
- IPO Date
- Mar 6, 2018
- Website
- vivocannabis.com
- Similar Companies
- Business
- VIVO Cannabis Inc. (VVCIF), a Canadian licensed producer of medical and recreational cannabis products, operates as a wholly-owned subsidiary of MediPharm Labs Corp. following its acquisition in an all-stock transaction effective April 2023; the company holds production, sales, and research licenses from Health Canada and maintains a 300,000-square-foot indoor cultivation facility in Napanee, Ontario, where it cultivates, processes, and packages dried flower, pre-rolled joints, and cannabis oils. Core products and services encompass premium cannabis brands including Canna Farms, Beacon Medical, Fireside, and Lumina, offering dried flower, pre-rolls, oils, vape cartridges, soft gels, and fast-acting sublinguals; it also provides medical cannabis through the Harvest Medicine clinic network, servicing over 200,000 patient visits via direct-to-patient sales and the HMED Connect telemedicine platform, alongside wholesale supply to provincial retailers such as the Ontario Cannabis Store, Alberta Gaming, Liquor and Cannabis Commission, and British Columbia Liquor Distribution Branch. Founded in 2014 as ABcann Global and rebranded to VIVO Cannabis in early 2019, the company is headquartered in Napanee, Ontario, with additional facilities in Hope, British Columbia, and pursues international medical cannabis opportunities in Germany and Australia through EU-GMP certification for flower cultivation and packaging. Recent developments include the completed merger with MediPharm Labs in April 2023, enhancing product portfolios with pharmaceutical-quality concentrates and enabling revenue synergies projected at $7 million to $9 million annually; in May 2025, MediPharm announced the pending $4.5 million cash sale of VIVO's Hope, British Columbia facility, set to close in June 2025 to strengthen the balance sheet.
Cicatrix Labs Teams Up VIVO Cannabis On Launch Of Assuage Brand Suppositories
VIVO Cannabis(TM) Adds Craft Licensed Producer, Delta 9 to Online Medical Marketplace
VIVO Cannabis(TM) Provides Strategic Update for a Medical Cannabis Focus
VIVO Cannabis(TM) Announces Second Quarter 2021 Results
VIVO Cannabis(TM) Adds Craft Licensed Producer Truro Cannabis to Online Medical Marketplace
VIVO Cannabis(TM) Launches Canna Farms(TM) Brick Hash and Large Format Pink Kush Flower to Online Medical Marketplace
VIVO Cannabis(TM) Announces Results of 2021 AGM and Election of New Directors
VIVO Announces Board Changes
VIVO Cannabis(TM) Launches Premium Topical CBD Cream Infused with Terpenes: Unique Formulation Designed for Medical Users
Cannabis Movers & Shakers: TILT, BRNT, ECGI, Alcanna, WeedMD, Mind Cure, The FLowr Corporation, VIVO, Cannabiz, Team Hytiva